CHITOGENX REPORTS ITS THIRD QUARTER 2023 RESULTS

Successful completion of initial portion of U.S. Phase I/II ORTHO-R rotator cuff tear repair clinical trial Balance sheet restructured with $5.8 million...

Related Keywords

California ,United States ,Montreal ,Quebec ,Canada ,Canadian ,Frederic Dumais ,Philippe Deschamps ,Luc Mainville ,Ortho Regenerative Technologies Inc ,California Medical Innovations Institute ,Data Safety Monitoring Committee ,Chitogenx Inc ,Chitogenx Senior Vice President ,Chief Financial Officer ,Ortho Regenerative Technologies ,Regenerative Technologies ,Chief Executive Officer ,Senior Vice President ,Director Communications ,Investor Relations ,